|
 Previous Article | Table of Contents | Next Article 
Stem cell factor and basic fibroblast growth factor are synergistic in
augmenting committed myeloid progenitor cell growth
JL Gabrilove, K White, Z Rahman and EL Wilson
Laboratory of Leukocyte Biology, Sloan Kettering Institute, New York, NY
10021.
Stem cell factor (SCF) and basic fibroblast growth factor (bFGF) are
hematopoietic cytokines produced by bone marrow stromal cells. It is known
that, although SCF and bFGF have limited clonogenic activity on their own,
they can augment colony-stimulating factor (CSF)-mediated progenitor cell
growth. Because these factors are both sequestered by stromal cells, we
examined their interaction on progenitor cell growth in conjunction with
granulocyte-macrophage-CSF (GM-CSF). In this study, we show that clonogenic
growth derived from low-density bone marrow cells stimulated by GM-CSF is
significantly augmented (P < .001) in the presence of maximal (100
ng/mL) concentrations of SCF in combination with 100 ng/mL of bFGF. When
CD34+ cells are used, the synergistic effect of bFGF and SCF for
GM-CSF-mediated progenitor cell growth is further increased, resulting in
as much as a sevenfold increase in detectable colony-forming units
granulocyte-macrophage (P < .001). These data suggest that the
synergistic activity of bFGF and SCF is mediated directly on hematopoietic
precursors. These observations suggest that bFGF and SCF, concentrated
locally on stromal cell surfaces, might interact in concert with other
hematopoietic cytokines to regulate stem cell proliferation and
differentiation in hematopoietic niches in the bone marrow.
Volume 83,
Issue 4,
pp. 907-910,
02/15/1994
Copyright © 1994 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
T. Nakayama, N. Mutsuga, and G. Tosato
Effect of Fibroblast Growth Factor 2 on Stromal Cell-Derived Factor 1 Production by Bone Marrow Stromal Cells and Hematopoiesis
J Natl Cancer Inst,
February 7, 2007;
99(3):
223 - 235.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. N. Salm, P. E. Burger, S. Coetzee, K. Goto, D. Moscatelli, and E. L. Wilson
TGF-{beta} maintains dormancy of prostatic stem cells in the proximal region of ducts
J. Cell Biol.,
July 4, 2005;
170(1):
81 - 90.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Karp, I. Gojo, R. Pili, C. D. Gocke, J. Greer, C. Guo, D. Qian, L. Morris, M. Tidwell, H. Chen, et al.
Targeting Vascular Endothelial Growth Factor for Relapsed and Refractory Adult Acute Myelogenous Leukemias: Therapy with Sequential 1-{beta}-D-Arabinofuranosylcytosine, Mitoxantrone, and Bevacizumab
Clin. Cancer Res.,
June 1, 2004;
10(11):
3577 - 3585.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Okada, A. Montero, X. Zhang, T. Sobue, J. Lorenzo, T. Doetschman, J. D. Coffin, and M. M. Hurley
Impaired Osteoclast Formation in Bone Marrow Cultures of Fgf2 Null Mice in Response to Parathyroid Hormone
J. Biol. Chem.,
May 30, 2003;
278(23):
21258 - 21266.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. E. Burger, S. Coetzee, W. L. McKeehan, M. Kan, P. Cook, Y. Fan, T. Suda, R. P. Hebbel, N. Novitzky, W. A. Muller, et al.
Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells
Blood,
November 15, 2002;
100(10):
3527 - 3535.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Bikfalvi, S. Klein, G. Pintucci, and D. B. Rifkin
Biological Roles of Fibroblast Growth Factor-2
Endocr. Rev.,
February 1, 1997;
18(1):
26 - 45.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
C. Richard, J. P. Liuzzo, and D. Moscatelli
Fibroblast Growth Factor-2 Can Mediate Cell Attachment by Linking Receptors and Heparan Sulfate Proteoglycans on Neighboring Cells
J. Biol. Chem.,
October 13, 1995;
270(41):
24188 - 24196.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
